About Trevi

Trevi Health Ventures is a healthcare investment firm with over $100 million under management. The investment team combines experienced investment professionals and senior-level executives and entrepreneurs with proven track records.

Trevi provides development and growth capital for private healthcare companies with emphasis on medical devices, biopharmaceuticals and healthcare services.

The firm was founded in 2005 and has offices in New York and London. The firm directly invests $5-10 million in each company. The firm also has strategic affiliations that provide flexible sources of capital for larger transactions, including growth capital, buy-outs, recapitalizations and debt financings.


  • November 13, 2008: Optovue Reaches Milestone with Placement of 1000th RTVue FD-OCT
  • October 28, 2008: Ikonisys Receives FDA Clearance for Non-Invasive, HER-2 Breast Cancer Test
  • September 21, 2008: Calypso® Medical Technologies Reports Advancements in Radiation Treatment for Cancer Patients
  • September 18, 2008: Ikonisys to Present at UBS Global Life Sciences Conference